Antihypertensive efficacy and tolerability of barnidipine hydrochloride in patients with renal parenchymal hypertension

Current Therapeutic Research - Clinical and Experimental

Volumn 61, Issue 7, 2000, Pages 395-405

  Huh, Woo Sung ^a   Kim, Yun Soo ^b   Han, Jin Suk ^b,e   Kim, Suhng Gwon ^b   Kim, Soon Bae ^c   Park, Jung Sik ^c   Yamamoto, Minoru ^d  

^a Sungkyunkwan University   (South Korea)

^b Seoul National University   (South Korea)

^c Asan Medical Center   (South Korea)

^d ASTELLAS PHARMA INC   (Japan)

^e Seoul National University Hospital   (South Korea)

Author keywords

Barnidipine hydrochloride; Calcium channel blocker; Renal hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; MEPIRODIPINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOSE CALCULATION; DRUG EFFICACY; DRUG TOLERABILITY; HEADACHE; HUMAN; HYPOTENSION; KIDNEY PARENCHYMA; PRIORITY JOURNAL; PRURITUS; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE;

EID: 0033865659     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(00)80022-3     Document Type: Article

References (22)

1. 1. Barkris GL. The role of combination antihypertensive therapy and the progression of renal disease hypertension: Looking toward the next millennium. Am J Hypertens. 1998;10(Suppl 2):158S-162S.
2. 2. Koomans HA, Roos JC, Boer P. Salt sensitivity of blood pressure in chronic renal failure. Evidence for renal control of body fluid distribution in man. Hypertension. 1982;4:190-197.
3. 3. Converse RL, Jacobsen TN, Toto RD. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327:1912-1918.
4. 4. Klahr S, Levey AS, Beck GJ. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med. 1994;330:877-884.
5. 5. Hall WD, Kusek JW, Kirk KA, et al. Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: The African-American Study of Kidney Disease and Hypertension pilot study. Am J Kidney Dis. 1997;29:720-728.
6. 6. Gilman AG, Rall TW, Nies AS, Taylor P. Drugs used for the treatment of angina. In: Gilman AG, ed. The Pharmacological Basis of Therapeutics. 8th ed. New York: Pergamon Press; 1990:774-780.
7. 7. Millard RW, Lathrop DA, Grupp G, et al. Differential cardiovascular effects of calcium channel blocking agents: Potential mechanisms. Am J Cardiol. 1982;49:429-506.
8. 8. Abe K, Kuwashima I, Imai J, et al. An effect of long-acting calcium channel blocker, barnidipine on 24-hour blood pressure. Ther Res. 1999;20:255-271.
9. 9. Yoshinaga K, Iimura K, Abe E, et al. Clinical evaluation of YM730 (mepirodipine hydrochloride) on essential hypertension. Igaku No Ayumi. 1991;156:543-560.
10. 10. Nakayama K, Kashiwabara T, Yamada S, Tanaka Y. Assessment in pig coronary artery of long-lasting and potent calcium antagonistic actions of the novel dihydropyridine derivative mepirodipine hydrochloride. Arzneim-Forsch Drug Res. 1989;39:50-55.
11. 11. Noda H, Fujita T. Effect of YM730 (mepirodipine hydrochloride), a new calcium antagonist, on systemic and local hemodynamics in essential hypertension. Clin Rep. 1990;24: 291-297.
12. 12. Guidelines Subcommittee. 1993 Guidelines for the management of mild hypertension: Memorandum from a World Health Organization/International Society of Hypertension meeting. ISH Hypertens News. 1993;6:3-16.
13. 13. Yoshinaga K, Iimura K, Abe K, et al. Clinical study of a calcium antagonist, mepirodipine hydrochloride, in renal hypertension. Kidney Dialysis. 1990;18:165-178.
14. 14. Inagaki O, Honda K, Takenaka T, Nakagawa C. Diuretic effect of barnidipine hydrochloride (YM-90730-5), a new calcium antagonist, in spontaneously hypertensive rats. Clin Rep. 1992;26:433-439.
15. 15. Inagaki O, Yatsu Y, Kasai C, Asano M. Renal effect of YM-09730-5, a new calcium antagonist. Clin Rep. 1990;24:665-674.
16. 16. Saitoh M, Kasai C, Ishikawa J, et al. Effect of barnidipine on blood flow to major organs and renal function in anaesthetized dogs and spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1995:22(Suppl 1):S339-S341.
17. 17. Kitajima K, Hayashi M, Suzuki Y, Saruta K. Pharmacokinetics of a calcium antagonist, YM730 (mepirodipine hydrochloride), in hypertensive patients with renal insufficiency. Kidney Dialysis. 1990;29:809-816.
18. 18. Kimura K, Suzuki N, Mise N, et al. Effects of barnidipine hydrochloride, a calcium channel blocker, on renal microcirculation in rats: A pilot study. Curr Ther Res. 1998; 59:826-834.
19. 19. Yuasa S, Shoji T, Sumikura T, et al. Effects of barnidipine hydrochloride on blood pressure and renal function in patients with renal hypertension. Prog Med. 1995;15:2378-2382.
20. 20. Hashimoto K, Motomura S, Tsujimoto G, et al. Phase I study of a calcium antagonist, YM730 (mepirodipine hydrochloride). Clin Rep. 1990;24:247-262.
21. 21. Grimm RH Jr, Leon AS, Hunninghake DB, et al. Effect of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: A double-blind controlled trial. Ann Intern Med. 1981;94:7-11.
22. 22. Suzuki N, Matsuoka H, Toda G. Effects of long term administration of a calcium antagonist, mepirodipine hydrochloride (YM730), on antihypertensive action, serum lipid and glucose metabolism in patients with essential hypertension. Ther Res. 1990;67:303-310.